Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890812 · ClinicalTrials.gov registry record
Factor XI Levels in Acute Ischemic Stroke
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 450
- Enrollment target
NCT00890812: Completed study, sponsored by University of Utah.
NCT00890812 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00890812 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the utility of measuring coagulation factor activities in the setting of acute ischemic stroke, as potential markers of inherited thrombotic risk. The investigators will determine if relationships exist between coagulation factors, including factor VIII, factor IX, and factor XI and clinical diagnosis, classification, and outcome. The investigators will determine if any significant elevations of these factor activities are independent thrombotic risk factors. Null Hypothesis: There is no statistical difference between coagulation factors, including factors VIII, IX, or XI activity levels in patients having acute ischemic stroke as compared to acute stroke mimics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-07 |
What the finished NCT00890812 record still lists
NCT00890812 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00890812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00890812 about?
NCT00890812 is a clinical study titled "Factor XI Levels in Acute Ischemic Stroke". The purpose of this study is to evaluate the utility of measuring coagulation factor activities in the setting of acute ischemic stroke, as potential markers of inherited thrombotic risk. The investigators will determine if relationships exist between coagulation factors, including factor VIII, fact...
What is the current status of trial NCT00890812?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2009-05. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00890812?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia